查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2045975

糖尿病採血針市場－全球產業規模、佔有率、趨勢、機會和預測：按產品類型、規格尺寸、應用、最終用戶、地區和競爭格局分類，2021-2031年

Diabetic Lancets Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Gauge Size, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 188 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球糖尿病採血針市場（一種用於採集毛細血管血進行血糖值測量的無菌一次性醫療設備）預計將從 2025 年的 25.4 億美元成長到 2031 年的 43.8 億美元，複合年成長率為 9.51%。

這一成長主要源於全球糖尿病患者人數的不斷增加，以及持續血糖值監測對於預防併發症的必要性。例如，國際糖尿病聯盟（IDF）報告稱，到2025年，全球約有5.89億成年人將患有糖尿病。病患群體的擴大，加上開發中國家糖尿病管理產品健保覆蓋範圍的擴大，顯著推高了對這些必需耗材的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 25.4億美元
市場規模：2031年 43.8億美元
複合年成長率：2026-2031年 9.51%
成長最快的細分市場 血紅素檢測
最大的市場 北美洲

然而，持續血糖監測（CGM）系統的快速普及為市場擴張帶來了巨大挑戰。這些先進的系統使患者無需反覆皮膚穿刺即可監測血糖值，從而減少了頻繁且具有侵入性的指尖採血測試的需求。這種技術變革可能會對傳統採血針市場的未來銷售成長造成相當大的限制。

市場促進因素

糖尿病採血針市場的主要驅動力是全球糖尿病盛行率的激增，這從根本上擴大了需要常規血糖監測的患者群體。都市化和生活方式的改變加劇了代謝性疾病危機，隨著需要頻繁血糖監測的患者人數增加，一次性採血針的需求正以前所未有的速度成長。近期流行病學數據也印證了這個趨勢，顯示疾病負擔遠高於先前的估計。世界衛生組織（WHO）在2024年11月發布的報告顯示，自1990年以來，全球糖尿病成人患者人數增加了四倍，目前已超過8億。如此龐大的患者群體直接推動了採血針的持續大量消耗，尤其是在連續監測技術尚未實現經濟可行性的地區。例如，Embeta公司在2024年12月發布的報告顯示，其年銷售額達11.3億美元，這充分反映了糖尿病注射和檢測用品行業的龐大商業規模。

同時，人們對早期檢測和血糖監測的日益重視，揭示了尚未開發的市場領域，從而推動了篩檢和預防醫學領域對採血針的需求。公共衛生和教育工作日益注重識別無症狀個體，以預防嚴重的長期併發症，而這項策略高度依賴採血針輔助的毛細血管採血，用於初步診斷和常規抽血檢查。未確診族群的市場規模龐大，根據國際糖尿病聯盟（IDF）2025年4月發布的報告，約有2.52億成年人尚未確診。隨著醫療保健系統積極將這一群體作為目標人群，以降低未來的醫療成本，預計採血針和標準型採血針在篩檢項目中的使用量將大幅成長，儘管面臨來自先進監測技術的競爭，但仍將進一步推動市場成長。

市場挑戰

全球糖尿病採血針市場正面臨嚴峻挑戰，主要原因是持續血糖監測（CGM）系統的廣泛應用。與每次血糖值測量都需要反覆刺穿皮膚的傳統檢測方法不同，CGM 設備使用皮下感測器，可長時間提供即時數據。這顯著減少了頻繁指尖採血的需求。隨著患者越來越傾向於半自動監測方案而非手動檢測，這項技術進步正在從根本上顛覆採血針產業傳統的高銷售量、持續獲利模式。

隨著持續血糖監測（CGM）的應用範圍從第1型糖尿病擴展到更為龐大的第二型糖尿病患者族群，這種轉變的影響日益顯著。根據國際糖尿病聯盟（IDF）預測，到2025年，第2型糖尿病患者將佔所有糖尿病患者的90%以上。由於醫療指南越來越建議對這一龐大的患者群體進行基於感測器的監測以加強血糖控制，一次性採血採血針的商業性需求顯然將會下降。因此，採血針的作用正在從日常必需品轉變為主要用於不定期校準和初步測試的輔助工具。

市場趨勢

糖尿病採血針市場的一個顯著趨勢是自伸縮式安全機制的廣泛應用，這主要得益於醫療機構對保護醫護人員免受血液傳播病原體侵害的高度重視。這種新機制以安全設計的產品取代了傳統的裸露針頭採血針，這些產品在使用後會自動存儲針頭，保護鋒利的針尖，從而消除意外針刺傷的風險。職業安全統計數據凸顯了這項轉變的重要性。例如，MedPro Disposal在2025年12月發布的報告顯示，美國超過80%的經皮暴露事件是由針刺傷造成的。因此，醫療機構正擴大採用這些一次性自回縮裝置，以確保符合監管要求，並降低與醫護人員受傷相關的重大經濟和健康風險。

同時，為了應對一次性糖尿病醫療用品對環境造成的巨大影響，該產業正做出關鍵性轉變，轉向使用環保且可生物分解的材料。製造商正擴大用植物來源聚合物等永續替代品和極簡包裝設計來取代傳統的醫用塑膠，以解決日益嚴重的醫療廢棄物問題。這一轉變得到了糖尿病管理對環境影響的明確數據的支持。根據 Healio 2025 年 4 月發布的報告，每位糖尿病患者平均每月排放2.7 至 3.3 磅與疾病相關的廢棄物。如此巨大的廢棄物量迫使產業相關人員將永續性融入產品的整個生命週期中，以滿足不斷變化的消費者需求和環境法規的要求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：糖尿病採血針全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類型（標準採血針、安全採血針、手動採血針、自動/壓力式採血針）
    • 針號分類（22G 或以下，23G 至 33G，33G 或以上）
    • 依申請項目（血糖測試、血紅素測試、膽固醇測試、血液凝固檢驗、過敏測試、新生兒檢查等）
    • 依最終使用者（醫院/診所、診斷中心、居家醫療、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美糖尿病採血針市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲糖尿病採血針市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區糖尿病採血採血針市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲糖尿病採血針市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲糖尿病採血針市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球糖尿病採血針市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • B. Braun SE
  • Terumo Medical Corporation
  • Medline Industries, LP
  • F. Hoffmann-La Roche Ltd.
  • ARKRAY, Inc.
  • Astellas Pharma Inc.
  • Becton, Dickinson and Company
  • Nipro Corporation
  • Medical Technology and Devices SpA
  • Allison Medical, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27565

The global market for diabetic lancets, which are sterile, disposable devices used to obtain capillary blood for glucose analysis, is projected to expand from USD 2.54 billion in 2025 to USD 4.38 billion by 2031, demonstrating a compound annual growth rate of 9.51%. This growth is predominantly fueled by the increasing worldwide prevalence of diabetes and the essential requirement for consistent blood glucose monitoring to avert health complications. For instance, the International Diabetes Federation reported that around 589 million adults globally were living with diabetes in 2025. This expanding patient demographic, coupled with broader healthcare coverage for diabetes management products in developing economies, significantly underpins the demand for these crucial consumables.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.54 Billion
Market Size 2031USD 4.38 Billion
CAGR 2026-20319.51%
Fastest Growing SegmentHaemoglobin Testing
Largest MarketNorth America

However, the market's expansion faces a notable challenge due to the accelerating adoption of continuous glucose monitoring (CGM) systems. These advanced systems reduce the necessity for frequent invasive finger-prick testing by enabling patients to track their glucose levels without repeated skin punctures. This technological shift poses a considerable constraint on the future volume growth of the conventional lancet market.

Market Driver

The primary catalyst for the diabetic lancets market is the escalating global prevalence of diabetes mellitus, which fundamentally enlarges the patient base needing daily glucose management. Urbanization and evolving lifestyles are fueling a metabolic health crisis, leading to an unprecedented surge in patients requiring frequent blood glucose testing, thereby increasing the demand for disposable lancing devices. Recent epidemiological data corroborates this trend, indicating a significantly higher disease burden than previously estimated. As reported by the World Health Organization in November 2024, the number of adults with diabetes worldwide has quadrupled since 1990, now exceeding 800 million. This substantial patient population directly drives the sustained, high-volume consumption of lancets, particularly in regions where continuous monitoring technologies are not yet economically viable. The vast commercial scale of the diabetes injection and testing supplies sector is evident, for instance, in Embecta Corp.'s December 2024 report of $1.13 billion in annual revenues.

Concurrently, heightened awareness concerning early detection and glucose monitoring is revealing a considerable untapped market segment, boosting demand for lancets in screening and preventative care. Public health and educational efforts are increasingly concentrating on identifying asymptomatic individuals to prevent severe long-term complications, a strategy heavily dependent on capillary blood sampling with lancets for initial diagnosis and routine spot-checking. The scale of this undiagnosed market is significant; the International Diabetes Federation's April 2025 update noted that around 252 million adults living with diabetes remain undiagnosed. As healthcare systems proactively target this population to reduce future medical expenses, the use of both safety and standard lancets in screening programs is anticipated to increase sharply, further bolstering market growth despite the competition from advanced monitoring technologies.

Market Challenge

The global diabetic lancets market faces a considerable hurdle primarily due to the extensive technological shift towards Continuous Glucose Monitoring (CGM) systems. In contrast to conventional testing, which demands repeated skin punctures for each glucose measurement, CGM devices employ subcutaneous sensors to deliver real-time data over prolonged durations. This significantly curtails the need for frequent finger-stick tests. This technological evolution fundamentally disrupts the high-volume, recurring revenue model typical of the lancet industry, as patients increasingly favor semi-automated monitoring solutions over manual testing.

The implications of this transition are becoming more pronounced as CGM adoption broadens from Type 1 diabetes to include the much larger Type 2 patient population, which, according to the International Diabetes Federation in 2025, accounted for over 90% of all individuals with diabetes. As healthcare standards increasingly recommend sensor-based monitoring for this vast group to enhance glycemic management, the commercial demand for disposable lancets is set for a clear decline. Subsequently, the role of lancets is transitioning from a daily essential to a supplemental tool, primarily used for infrequent calibration or as a backup testing method.

Market Trends

A prominent trend in the diabetic lancets market is the extensive adoption of automatic retractable safety mechanisms, driven by healthcare systems' strong emphasis on protecting staff from bloodborne pathogens. This involves replacing traditional lancets with exposed needles with safety-engineered versions that automatically retract and shield the sharp tip post-use, thereby eliminating the risk of accidental needle-stick injuries. The critical nature of this shift is highlighted by occupational safety statistics; for example, MedPro Disposal reported in December 2025 that needle-stick injuries account for over 80% of all percutaneous exposure incidents in the United States. Consequently, healthcare facilities are increasingly implementing these single-use, auto-disabling devices to ensure regulatory compliance and reduce the significant financial and health liabilities linked to staff injuries.

Concurrently, the industry is witnessing a crucial transition towards eco-friendly and biodegradable materials, a direct response to the considerable environmental impact of disposable diabetes supplies. Manufacturers are increasingly substituting conventional medical-grade plastics with sustainable alternatives, such as plant-based polymers and designs that minimize packaging, to tackle the growing problem of medical waste. This move is supported by clear data on the ecological burden of diabetes management; according to Healio in April 2025, an average individual with diabetes generates between 2.7 lb and 3.3 lb of disease-related waste monthly. This substantial volume of waste compels industry participants to embed sustainability throughout their product lifecycles, aligning with changing consumer demands and environmental regulations.

Key Market Players

  • B. Braun SE
  • Terumo Medical Corporation
  • Medline Industries, LP
  • F. Hoffmann-La Roche Ltd.
  • ARKRAY, Inc.
  • Astellas Pharma Inc.
  • Becton, Dickinson and Company
  • Nipro Corporation
  • Medical Technology and Devices S.p.A.
  • Allison Medical, Inc.

Report Scope

In this report, the Global Diabetic Lancets Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diabetic Lancets Market, By Product Type

  • Standard Lancets
  • Safety Lancets
  • Manually Activated
  • Automatically Activated/Pressure Activated

Diabetic Lancets Market, By Gauge Size

  • 22G and Below
  • 23G-33G
  • Above 33G

Diabetic Lancets Market, By Application

  • Glucose Testing
  • Haemoglobin Testing
  • Cholesterol Testing
  • Coagulation Testing
  • Allergy Testing
  • Neonatal Testing
  • Others

Diabetic Lancets Market, By End User

  • Hospitals & Clinics
  • Diagnostic Centers
  • Home Care Settings
  • Others

Diabetic Lancets Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diabetic Lancets Market.

Available Customizations:

Global Diabetic Lancets Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diabetic Lancets Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Standard Lancets, Safety Lancets, Manually Activated, Automatically Activated/Pressure Activated)
    • 5.2.2. By Gauge Size (22G and Below, 23G-33G, Above 33G)
    • 5.2.3. By Application (Glucose Testing, Haemoglobin Testing, Cholesterol Testing, Coagulation Testing, Allergy Testing, Neonatal Testing, Others)
    • 5.2.4. By End User (Hospitals & Clinics, Diagnostic Centers, Home Care Settings, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Diabetic Lancets Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Gauge Size
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Diabetic Lancets Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Gauge Size
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Diabetic Lancets Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Gauge Size
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Diabetic Lancets Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Gauge Size
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Diabetic Lancets Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Gauge Size
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Diabetic Lancets Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Gauge Size
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Diabetic Lancets Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Gauge Size
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Diabetic Lancets Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Gauge Size
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Diabetic Lancets Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Gauge Size
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Diabetic Lancets Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Gauge Size
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Diabetic Lancets Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Gauge Size
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Diabetic Lancets Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Gauge Size
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Diabetic Lancets Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Gauge Size
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Diabetic Lancets Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Gauge Size
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Diabetic Lancets Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Gauge Size
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Diabetic Lancets Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Gauge Size
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Diabetic Lancets Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Gauge Size
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Diabetic Lancets Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Gauge Size
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Diabetic Lancets Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Gauge Size
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Diabetic Lancets Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Gauge Size
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Diabetic Lancets Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Gauge Size
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Diabetic Lancets Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Gauge Size
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Diabetic Lancets Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Gauge Size
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Diabetic Lancets Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Gauge Size
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Diabetic Lancets Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. B. Braun SE
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Terumo Medical Corporation
  • 15.3. Medline Industries, LP
  • 15.4. F. Hoffmann-La Roche Ltd.
  • 15.5. ARKRAY, Inc.
  • 15.6. Astellas Pharma Inc.
  • 15.7. Becton, Dickinson and Company
  • 15.8. Nipro Corporation
  • 15.9. Medical Technology and Devices S.p.A.
  • 15.10. Allison Medical, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer